Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 418 of 1,261
  1. US 10675288

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  2. US 10675308

    Chinese medicine extract and preparation method and application thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  3. US 10676537

    Antibody targeted to tissue factor, preparation method therefor, and use thereof

    SHANGHAI MIRACOGEN INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  4. US 10676740

    Modified iRNA agents

    Alnylam Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  5. US 10676533

    Methods of treatment of CD123 overexpressing disorders

    Aptevo Research and Development LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  6. US 10676792

    Prognostic and diagnostic methods for colorectal cancer

    The Regents of the University of California · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  7. US 10676759

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  8. US 10676534

    Vaults engineered for hydrophobic drug delivery

    The Regents of the University of California · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  9. US 10676528

    Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  10. US 10676486

    Macrocyclic RIP2 kinase inhibitors

    Oncodesign SA · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  11. US 10676480

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  12. US 10676498

    Processes for the preparation of sofosbuvir and intermediates thereof

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  13. US 10676527

    Methods and compositions for modulation of blood-neural barrier

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  14. US 10676475

    Compounds for improving mRNA splicing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  15. US 10676452

    Compound for the prophylaxis or treatment of organ damage

    Sulfateq B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  16. US 10675482

    Device and method for use of photodynamic therapy

    Craniovation, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  17. US 10675360

    Targeted therapeutics

    Madrigal Pharmaceuticals, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  18. US 10676442

    Salt derivative of tetrahydroisoquinoline and crystalline thereof and preparation method therefore and application thereof

    China State Institute of Pharmaceutical Industry · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  19. US 10675488

    Acne removing skin care product and preparation method thereof

    INFINITUS (CHINA) COMPANY LTD. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  20. US 10676461

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  21. US 10675348

    Antibodies that bind human C6 and uses thereof

    REGENESANCE B.V. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  22. US 10675324

    Compositions and methods for modulating AT2R activity

    NOVOPYXIS INC. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  23. US 10676473

    Solid state forms of fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted
  24. US 10675356

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.